Abstract: Compounds are provided that comprise a ligand having a 5-substituted 2-phenylquinoline. In particular, the 2-phenylquinoline may be substituted with a cycloalkyl containing group at the 5-position. These compounds may be used in organic light emitting devices, in particular as red emitters in the emissive layer of such devices, to provide devices having improved properties.

Abstract: A compound having a structure of Formula I, provided. In Formula I, each of R1 to R7 is hydrogen or phenyl or a system consisting of two to ten phenyl groups connected to each other; at least two of R1 to R7 are not hydrogen; each of R8 and R9 are phenyl or a system consisting of two to ten phenyl groups connected to each other; X is O, S, or Se; and L is a direct bond or In the structure of L, m is an integer from 1 to 5, and RA is hydrogen, an aromatic or a heteroaromatic ring. Formulations, OLEDs, and consumer products containing the same are also provided.

Abstract: Compounds are provided that comprise a ligand having a 5-substituted 2-phenylquinoline. In particular, the 2-phenylquinoline may be substituted with a cycloalkyl containing group at the 5-position. These compounds may be used in organic light emitting devices, in particular as red emitters in the emissive layer of such devices, to provide devices having improved properties.

Abstract: Provided are organometallic compounds. Also provided are formulations comprising these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.

Abstract: Provided are organometallic compounds. Also provided are formulations comprising these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.

Abstract: Provided are phenylthienothiazole containing compounds. The compound of the present invention comprises a first phenylthienothiazole-derived ligand LA according to Formula I as described herein which is coordinated to Ir to form a 5-membered chelate ring. Also provided are formulations comprising these compounds. Further provided are OLEDs and related consumer products that utilize these compounds.

Abstract: Provided are fused-indole containing compounds which contain as a further structural unit at least one of pyrimidine, triazine, quinazoline, benzene, biphenyl, terphenyl, naphthalene, phenanthrene, anthracene, triphenylene, pyridine, pyrazine, fluorene, dibenzofuran, dibenzothiophene, carbazole, quinoline, isoquinoline, triarylboryl or quinoxaline, which may be further substituted. Also provided are formulations comprising these compounds. Further provided are OLEDs and related consumer products that utilize these compounds.

Abstract: A compound including a first ligand LA of Formula I, is disclosed. In Formula I, ring B is a 5- or 6-membered ring; X1, X2, and X3 are each CRA or N; R is a 5- or 6-membered carbocyclic or heterocyclic ring, which can be further fused or substituted; and (1) when ring B is an unfused 6-membered ring, X1 and X2 are N, and X3 is C; and (2) when ring B is a fused 6-membered ring, ring B has the structure of Formula II, In this structure, the wavy line indicates the point of connection to ring A; Q1 to Q6 are each C or N; and, when proviso (2) applies, (I) at least one of X1, X2, and X3 is N; or (II) R is two or more fused or unfused 5- or 6-membered carbocyclic or heterocyclic rings, or (III) at least ring A or R is substituted with a partially or fully deuterated alkyl or partially or fully deuterated cycloalkyl group.

Abstract: Provided are organometallic compounds including a ligand LA of Formula I: Also provided are formulations including these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.

Abstract: A compound having a ligand LA of Formula I, is disclosed. In Formula I, ring B is a 5-membered or 6-membered ring; K is a direct bond, O, or S; X is O, S, Se, NR, CRR?, SiRR?, or GeRR?; R1 and R2 are each independently selected from a variety of substituents; each R, R?, RA, and RB is independently hydrogen or a substituent; LA is coordinated to a metal M selected from Os, Ir, Pd, Pt, Cu, Ag, or Au by the dashed lines; any two adjacent of R1, R2, R, R?, RA, or RB can be joined or fused to form a ring, with the proviso that when ring B is a 6-membered ring, two RB substituents are not joined to form a fused 6-membered aromatic ring. Organic light emitting devices, consumer products, formulations, and chemical structures containing the compounds are also disclosed.

Abstract: Provided are organometallic compounds having a structure of Also provided are formulations comprising these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.

Abstract: A compound comprising a heteroleptic iridium complex having a structure of Formula II, is provided. In Formula II, each of R1, R2, R3, R4, R5, and R6, is independently selected from the group consisting of hydrogen, deuterium, cycloalkyl, deuterated cycloalkyl, alkyl, and deuterated alkyl; at least one of R1, R2, R3, R4, R5, and R6 is not hydrogen or deuterium; and each R and R? is independently selected from a variety of substitutions. OLEDs and formulations containing the compound of Formula II are also provided.

Abstract: Ligands for metal complexes that are useful as phosphorescent emitters in OLEDs are disclosed. The ligands contain an aryl group covalently bonded to the coordinating metal. The aryl group has a cycloalkyl or a substituted cycloalkyl that is linked para to the linkage of the coordinating metal on that aryl group.

Abstract: Heteroleptic iridium complexes having the formula are disclosed. In this formula, R1, R2, R3, R4, R5, and R6, are selected from hydrogen, deuterium, cycloalkyl, deuterated cycloalkyl, alkyl, and deuterated alkyl, and can optionally be linked together to form a ring; at least one of R1, R2, R3, R4, R5, and R6 is cycloalkyl, deuterated cycloalkyl, alkyl, or deuterated alkyl; ring A is attached to the 4- or 5-position of ring B; and R and R? can represent any of a variety of subsitutents. These iridium compounds contain alkyl substituted phenylpyridine ligands, which provide these compounds with beneficial properties when the iridium complexes are incorporated into OLED devices.

Abstract: A novel compound is disclosed which includes a ligand LA of Formula I, Formula II, Formula III, or Formula IV: wherein: ring B is independently a 5-membered or 6-membered carbocyclic or heterocyclic ring; X1 to X4 are each independently selected from the group consisting of C, N, and CR; at least one pair of adjacent X1 to X4 are each C and fused to a structure of Formula V where indicated by “”; X5 to X12 are each independently C or N; the maximum number of N within a ring is two; Z and Y are each independently selected from the group consisting of O, S, Se, NR?, CR?R?, SiR?R?, and GeR?R?; RB and RC each independently represents zero, mono, or up to a maximum allowed substitutions to its associated ring; each of RB, RC, R, R?, and R? is independently hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl,

Abstract: Provided are organoiridium compounds. Also provided are formulations comprising these organoiridium compounds. Further provided are OLEDs and related consumer products that utilize these organoiridium compounds.

Abstract: A compound having an ancillary ligand L1 having the formula: Formula I is disclosed. The ligand L1 is coordinated to a metal M having an atomic number greater than 40, and two adjacent substituents are optionally joined to form into a ring. Such compound is suitable for use as emitters in organic light emitting devices.

Abstract: A phosphorescent metal complexes containing a ligand LA having the formula selected from is disclosed.

Abstract: Provided are multicyclic organic electroluminescent compounds having a ligand LA of Formula II Also provided are OLEDs and related consumer products that contain an organic layer comprising these organic electroluminescent compounds. Further provided are formulations comprising these organic electroluminescent compounds.

Abstract: Provided are compounds that include a ligand LA of Formula I